An interventional study of Osteopathic manipulative treatment and No intervention in Neck Pain, sponsored by Michigan State University. Completed at 3 sites in United States. Open to participants aged 21 Years to 65 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-10-20.
Sponsored by Michigan State University · Not applicable, Interventional, and Basic science
Cholewicki J, Popovich JM Jr, Reeves NP, DeStefano LA, Rowan JJ, Francisco TJ, Prokop LL, Zatkin MA, Lee AS, Sikorskii A, Pathak PK, Choi J, Radcliffe CJ, Rama…PubMed 34719122 ↗
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Among 174 studies in Neck Pain with a site in United States — 21 open to participants now, 30 under way, 2 of them phase 3. Neck Pain · United States.
Among the 174 studies in Neck Pain with a site in United States, this one is the 24th largest by enrollment of the 145 interventional ones that give a count, is one of 12 that started in 2014, is one of 113 with no phase, and was the 65th registered.
1,367 studies on the registry are indexed under Neck Pain; 301 are open to participants now.
Browse Neck Pain studies →21 of the 174 studies in Neck Pain with a site in United States are open now. Recruiting first, the newest first:
University of Houston · Sites in United States
Ages 18–60 · Women only · Healthy volunteers
University of Colorado, Denver · Sites in United States
Ages 18+
Indiana University · Sites in United States
Ages 18+ · Women only
University of Colorado, Denver · Sites in United States
Ages 21–84
San Diego State University · Sites in United States
Ages 18+
A study can be open while its sites in United States have not opened yet or have stopped. Only those recruiting at a site in United States →
Of the 158 Neck Pain studies recruiting now, 25 (16%) set no upper age limit and 120 (76%) stop at 75 or younger; 8 take children under 18; 27 take healthy volunteers.
This study: 21 Years to 65 Years · all sexes · healthy volunteers too.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
174 studies; the count open now beside each. This study's row is marked.
A study in two phases is counted once above. Listed by phase, each with its combined phases: Phase 1 10 · Phase 2 11 · Phase 3 9 · Phase 4 6
First in 1994; this study’s year is marked. 12 started in 2014.
By drug class, each counting the studies that test any of its medicines:
This study's enrollment of 154 is above the median of 50 across 1,122 interventional studies indexed under Neck Pain.
Median enrollment 60 across the 145 interventional studies, 82 across the 29 observational. Of the 120 that completed or were terminated, 24 (20%) have results posted.
This tab as a report to print or save as PDF → With an account.
17 of 174 have an industry lead sponsor. The 10 most frequent:
Michigan State University is the lead sponsor of 143 studies on the registry; 27 are open to participants now.
Michigan State University has 2 studies filed under Neck Pain — fewer than ten, so there is no comparison to draw.
12 of the studies in Neck Pain with a site in United States that are under way reach primary completion within a year, 1 of them phase 3. Phase 3 first, then by date:
| Study | Primary completion |
|---|---|
| NCT05052541Phase 3University of Colorado, DenverSafety and Efficacy of Oral Cannabis in Chronic Spine Pain | 2027-06 |
| NCT06906107Baylor UniversityValidating a Clinical Prediction Rule to Guide Manual Therapy and Exercise for Neck Pain Relief | 2026-12-31 |
| NCT06224829University of FloridaResponse to Massage in Neck Pain | 2026-12-31 |
| NCT06044649Rush University Medical CenterModerators and Mediators (M & M Trial) of Psychosocial Treatments of Chronic Pain | 2027-02-28 |
| NCT07290517Indiana UniversityAssessing Pain and Effectiveness of Carevix Device for IUD Insertions | 2027-03 |
Add all 12 to your calendar (.ics) → With an account.
Among the 174 studies in Neck Pain with a site in United States, from their registry updates:
This tab as a report to print or save as PDF → With an account.
The overall goal of this project is to develop sensitive and objective clinical research tools for the assessment of head-neck motor control. In order to accomplish this goal, the investigators aim to quantify changes in head-neck motor control before and after osteopathic manipulative treatment. The investigators hypothesize that head-neck motor control will improve in neck pain participants after 4-weeks of treatment. Additionally, the investigators will compare position and force head-neck motor control between healthy controls and neck pain patients. The investigators hypothesize that baseline tests of position and force head-neck motor control will be better in healthy individuals than neck pain patients.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
All participants must meet all of the inclusion criteria to participate in the study. Below is a list of inclusion criteria for ALL participants:
Below is an additional list of inclusion criteria for NECK PAIN participants:
Exclusion Criteria:
All candidates meeting any of the exclusion criteria at baseline will be excluded from study participation. Exclusion criteria will be self-reported. However, during each treatment session, the physicians will be watching for clinical signs and symptoms not consistent with physical findings that are suggestive of the presence of any of the exclusion criteria. In such a case, further treatment will be discontinued and the subject will be excluded.
Below is a list of exclusion criteria for ALL participants:
History of:
Unresolved symptoms from:
Current diagnosis of:
Conditions recognized by a physician any time during the study:
Below is an additional exclusion criterion for healthy control participants:
Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
Weight in kilograms divided by height in metres squared. Example: 70 kg and 1.75 m gives 70 ÷ (1.75 × 1.75) ≈ 22.9.
What counts as overweight or obesity differs between countries (some use lower cut-offs), so go by the range the study states.
A “mini-stroke”: temporary stroke-like symptoms caused by reduced blood flow to part of the brain, spinal cord or eye, without signs of a new stroke on a scan.
Stroke symptoms need emergency care at once, even if they go away.
Judged by the study doctor to matter for your health or for the study. It is a doctor’s decision, so ask the study team if you are unsure whether something counts.
Informed consent
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
BMI (body mass index)
Weight in kilograms divided by height in metres squared. Example: 70 kg and 1.75 m gives 70 ÷ (1.75 × 1.75) ≈ 22.9.
What counts as overweight or obesity differs between countries (some use lower cut-offs), so go by the range the study states.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
TIA (transient ischaemic attack)
A “mini-stroke”: temporary stroke-like symptoms caused by reduced blood flow to part of the brain, spinal cord or eye, without signs of a new stroke on a scan.
Stroke symptoms need emergency care at once, even if they go away.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Clinically significant
Judged by the study doctor to matter for your health or for the study. It is a doctor’s decision, so ask the study team if you are unsure whether something counts.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
This arm received osteopathic manipulative treatment (OMT) for approximately 4 weeks (once per week), then received no intervention after for approximately 4 weeks.
Procedure: Osteopathic manipulative treatment · Other: No intervention
This arm received no intervention after for approximately 4 weeks, then received osteopathic manipulative treatment (OMT) for approximately 4 weeks (once per week).
Procedure: Osteopathic manipulative treatment · Other: No intervention
In this arm, healthy controls are tested at baseline.
Up to 4 sessions of osteopathic manipulative treatment (once per week)
No interventions for approximately 4 weeks
Head Position Tracking Accuracy (Flexion/Extension)
Participants will be seated in an upright position with their upper body secured to a backrest and will wear a head harness with an attached position sensor. The angular position of the head will be displayed on a monitor 1 meter in front of the participants and they will be asked to follow a moving target by moving their head. Accuracy will be determined by taking the difference between the target position signal and the actual head position (root mean square error measured in degrees with string potentiometers).
Time frame: Measurements from Baseline, Week 4 and Week 8
Head Force Tracking Accuracy
Participants will be seated in an upright position with their upper body secured to a backrest and will be asked to generate force with their head against a fixed pad. The pad will be attached to a load cell that monitors how much force is being generated by their head. The force level will be displayed on a monitor 1 meter in front of the participants and they will be asked to follow a moving target by generating force with their head. Accuracy will be determined by taking the difference between target force signal and the actual head force (measured in Newtons with the load cell).
Time frame: Baseline, Week 4, and Week 8
Head Position Stabilization Accuracy
Participants will be sitting upright in a seat mounted to a robotic platform (Mikrolar Hexapod Robot) with their upper body secured to a backrest and will wear a head harness with an attached position sensor. The robotic platform will provide an angular perturbation to the participant about the cervical spine in the sagittal plane while the participant is asked to maintain (stabilize) their head position in the upright posture with their eyes open. Accuracy will be determined by measuring the amount of head displacement (measured in degrees with string potentiometers) during the perturbation trial.
Time frame: Baseline, Week 4, and Week 8
Neck Force Variability
Participants will be seated in an upright position with their upper body secured to a backrest and will be asked to generate force with their head against a fixed pad. They will be asked to performed 6-seconds isometric exertions in different directions. Measured forces are converted to moments (in Newton meters), and standard deviation of the moments are reported for flexion and extension. Larger the number in the variability indicates worse performance.
Time frame: Baseline, Week 4 (crossover), Week 8
Neck Muscle Activation Directionality
Participants will be seated in an upright position with their upper body secured to a backrest and will be asked to generate force with their head against a fixed pad. They will be asked to performed 6-seconds isometric exertions in different directions. Surface EMG will be recorded from the sternocliedomastoid (SCM), splenius capitis (SPC), and upper trapezius (UT) muscles. Muscle directionality will be determined from the EMG magnitude in each direction of exertion and represented as specificity index. Specificity index ranges from 0 to 1, where 0 indicates no muscle activity and 1 indicates the highest muscle activity. Higher number indicates worst outcome.
Time frame: Baseline, Week 4 (crossover), Week 8
Patient Reported Outcomes Measurement Information System (PROMIS)
Assesses weekly changes in physical function, anxiety, depression, fatigue, sleep, satisfaction with social role, and pain with PROMIS-29 questionnaire.
Time frame: Measurements from Baseline and Week 4 (crossover point)
Change in Concomitant Medication
Assesses weekly changes in the use of medication with a questionnaire. Patients were asked to report medications used within the past 7 days.
Time frame: Baseline, Week 4, Week 8
Change in Neck Disability
Assesses weekly changes in functional activities related to neck disability with the Neck Disability Index questionnaire.
Time frame: Measurements from Baseline, Week 4 (crossover point), and Week 8
Change in Fear Avoidance Behavior
Assesses weekly changes in fear avoidance behavior using the Fear Avoidance Beliefs questionnaire, assessing effects of fear-avoidance beliefs about physical activity and work. Patients rated statements on a scale from 0 (completely disagree) to 6 (completely agree). Scores are then summed for each category: "Physical activity" (total of 4 statements, ranges from 0 to 24), and "Work" (total of 7 statements ranges from 0 to 42). Higher scores indicate stronger fear-avoidance belief (i.e. worse outcome).
Time frame: Measurements from Baseline, Week 4 (crossover point), and Week 8
Participants were recruited from general population in the Greater Lansing area between June 2014 to August 2017.
| Milestone | OMT First, Then No Intervention | No Intervention, Then OMT | Healthy Control (no Neck Pain) |
|---|---|---|---|
| Started | 49 | 48 | 41 |
| Visit 1 - patient reported outcome (baseline) | 44 | 43 | 40 |
| Visit 1 - biomechanical testing (baseline) | 41 | 39 | 40 |
| Visit 2 - patient reported outcome (cross over) | 38 | 37 | 0 |
| Visit 2 - biomechanical testing (cross over) | 37 | 37 | 0 |
| Visit 3 - patient reported outcome | 37 | 37 | 0 |
| Visit 3 - biomechanical testing | 37 | 37 | 0 |
| Completed | 37 | 37 | 40 |
| Not completed | 12 | 11 | 1 |
| Withdrew: Lost to follow-up | 2 | 3 | 0 |
| Withdrew: Withdrawal by subject | 10 | 7 | 0 |
| Withdrew: Changes in inclusion/exclusion criteria | 0 | 1 | 1 |
Participants will be seated in an upright position with their upper body secured to a backrest and will wear a head harness with an attached position sensor. The angular position of the head will be displayed on a monitor 1 meter in front of the participants and they will be asked to follow a moving target by moving their head. Accuracy will be determined by taking the difference between the target position signal and the actual head position (root mean square error measured in degrees with string potentiometers).
| Degrees | OMT First, Then No Intervention | No Intervention, Then OMT | Healthy Control (no Neck Pain) |
|---|---|---|---|
| Baseline | 1.2104 ± 0.0641 | 1.2306 ± 0.0746 | 1.2108 ± 0.0579 |
| Week 4 | 1.2264 ± 0.0815 | 1.2258 ± 0.0599 | — |
| Week 8 | 1.2205 ± 0.0714 | 1.2247 ± 0.0678 | — |
Participants will be seated in an upright position with their upper body secured to a backrest and will be asked to generate force with their head against a fixed pad. The pad will be attached to a load cell that monitors how much force is being generated by their head. The force level will be displayed on a monitor 1 meter in front of the participants and they will be asked to follow a moving target by generating force with their head. Accuracy will be determined by taking the difference between target force signal and the actual head force (measured in Newtons with the load cell).
| Newtons | OMT First, Then No Intervention | No Intervention, Then OMT | Healthy Control (no Neck Pain) |
|---|---|---|---|
| Baseline | 1.2186 ± 0.0750 | 1.2601 ± 0.1187 | 1.1930 ± 0.0527 |
| Week 4 | 1.2103 ± 0.0873 | 1.2406 ± 0.1131 | — |
| Week 8 | 1.2185 ± 0.0826 | 1.2320 ± 0.1041 | — |
Participants will be sitting upright in a seat mounted to a robotic platform (Mikrolar Hexapod Robot) with their upper body secured to a backrest and will wear a head harness with an attached position sensor. The robotic platform will provide an angular perturbation to the participant about the cervical spine in the sagittal plane while the participant is asked to maintain (stabilize) their head position in the upright posture with their eyes open. Accuracy will be determined by measuring the amount of head displacement (measured in degrees with string potentiometers) during the perturbation trial.
| Degrees | OMT First, Then No Intervention | No Intervention, Then OMT | Healthy Control (no Neck Pain) |
|---|---|---|---|
| Baseline | 1.5560 ± 0.4951 | 1.7926 ± 0.6542 | 1.6905 ± 0.4729 |
| Week 4 | 1.4938 ± 0.5013 | 1.8118 ± 1.1645 | — |
| Week 8 | 1.5641 ± 0.7075 | 1.6380 ± 0.7075 | — |
Participants will be seated in an upright position with their upper body secured to a backrest and will be asked to generate force with their head against a fixed pad. They will be asked to performed 6-seconds isometric exertions in different directions. Measured forces are converted to moments (in Newton meters), and standard deviation of the moments are reported for flexion and extension. Larger the number in the variability indicates worse performance.
| Nm | OMT First, Then No Intervention | No Intervention, Then OMT | Healthy Control (no Neck Pain) |
|---|---|---|---|
| Baseline - Flexion Force Variability | 0.1513 ± 0.0884 | 0.2530 ± 0.3718 | 0.1593 ± 0.0831 |
| Week 4 - Flexion Force Variability | 0.1396 ± 0.0706 | 0.1920 ± 0.1470 | — |
| Baseline - Extension Force Variability | 0.1382 ± 0.1275 | 0.2932 ± 0.6775 | 0.1255 ± 0.0532 |
| Week 4 - Extension Force Variability | 0.1309 ± 0.1242 | 0.1746 ± 0.2135 | — |
| Week 8 - Extension Force Variability | 0.1391 ± 0.1676 | 0.1254 ± 0.0726 | — |
| Week 8 - Flexion Force Variability | 0.1307 ± 0.0557 | 0.1435 ± 0.0674 | — |
Participants will be seated in an upright position with their upper body secured to a backrest and will be asked to generate force with their head against a fixed pad. They will be asked to performed 6-seconds isometric exertions in different directions. Surface EMG will be recorded from the sternocliedomastoid (SCM), splenius capitis (SPC), and upper trapezius (UT) muscles. Muscle directionality will be determined from the EMG magnitude in each direction of exertion and represented as specificity index. Specificity index ranges from 0 to 1, where 0 indicates no muscle activity and 1 indicates the highest muscle activity. Higher number indicates worst outcome.
| Units on a scale | OMT First, Then No Intervention | No Intervention, Then OMT | Healthy Control (no Neck Pain) |
|---|---|---|---|
| Baseline - Right SCM specificity index | 0.3863 ± 0.1556 | 0.4476 ± 0.1402 | 0.4786 ± 0.1520 |
| Week 4 - Right SCM specificity index | 0.4211 ± 0.1387 | 0.4366 ± 0.1316 | — |
| Week 8 - Right SCM specificity index | 0.3995 ± 0.1471 | 0.4503 ± 0.1347 | — |
| Baseline - Right SPC specificity index | 0.3327 ± 0.1236 | 0.2979 ± 0.1108 | 0.3434 ± 0.1083 |
| Week 4 - Right SPC specificity index | 0.3408 ± 0.1589 | 0.2899 ± 0.0972 | — |
| Week 8 - Right SPC specificity index | 0.3685 ± 0.1368 | 0.2724 ± 0.1091 | — |
| Baseline - Right UT specificity index | 0.1877 ± 0.1394 | 0.1994 ± 0.1388 | 0.1906 ± 0.1268 |
| Week 4- Right UT specificity index | 0.2094 ± 0.1708 | 0.2166 ± 0.1519 | — |
| Week 8 - Right UT specificity index | 0.2188 ± 0.1356 | 0.2198 ± 0.1577 | — |
Assesses weekly changes in physical function, anxiety, depression, fatigue, sleep, satisfaction with social role, and pain with PROMIS-29 questionnaire.
| t-score | Osteopathic Manipulative Treatment (OMT) | No Intervention |
|---|---|---|
| Pain interference - Week 4 | 57.04 ± 0.84 | 56.97 ± 0.85 |
| Satisfaction with participation in social roles - Week 4 | 45.58 ± 1.00 | 46.76 ± 1.01 |
| Sleep disturbance - Week 4 | 53.11 ± 0.95 | 56.36 ± 0.96 |
| Fatigue - Week 4 | 54.09 ± 0.97 | 57.35 ± 0.99 |
| Depression - Week 4 | 47.33 ± 0.75 | 49.92 ± 0.76 |
| Anxiety - Week 4 | 49.23 ± 0.99 | 50.54 ± 1.00 |
| Physical function - Week 4 | 45.75 ± 0.78 | 44.40 ± 0.79 |
Assesses weekly changes in the use of medication with a questionnaire. Patients were asked to report medications used within the past 7 days.
| Number of medication | OMT First, Then No Intervention | No Intervention, Then OMT | Healthy Control (no Neck Pain) |
|---|---|---|---|
| Baseline | 2.2 ± 2.6 | 1.9 ± 2.6 | 0.7 ± 1.1 |
| Week 4 | 2.1 ± 2.2 | 2.2 ± 2.8 | — |
| Week 8 | 1.7 ± 2.4 | 2.1 ± 2.8 | — |
Assesses weekly changes in functional activities related to neck disability with the Neck Disability Index questionnaire.
| % (out of 50) | OMT First, Then No Intervention | No Intervention, Then OMT | Healthy Control (no Neck Pain) |
|---|---|---|---|
| Baseline | 34.6 ± 9.7 | 37.5 ± 9.1 | 1.9 ± 3.2 |
| Week 4 | 29.3 ± 11.7 | 36.5 ± 9.6 | — |
| Week 8 | 30.5 ± 12.1 | 30.9 ± 12.6 | — |
Assesses weekly changes in fear avoidance behavior using the Fear Avoidance Beliefs questionnaire, assessing effects of fear-avoidance beliefs about physical activity and work. Patients rated statements on a scale from 0 (completely disagree) to 6 (completely agree). Scores are then summed for each category: "Physical activity" (total of 4 statements, ranges from 0 to 24), and "Work" (total of 7 statements ranges from 0 to 42). Higher scores indicate stronger fear-avoidance belief (i.e. worse outcome).
| scores on a scale | OMT First, Then No Intervention | No Intervention, Then OMT | Healthy Control (no Neck Pain) |
|---|---|---|---|
| FABQ Work- Baseline | 13.32 ± 7.91 | 14.65 ± 9.10 | 4.28 ± 8.31 |
| FABQ Work- Week 4 | 12.92 ± 9.43 | 13.92 ± 7.92 | — |
| FABQ Work- Week 8 | 11.92 ± 8.10 | 14.97 ± 9.40 | — |
| FABQ Physical Activity - Baseline | 11.89 ± 5.62 | 12.49 ± 4.48 | 2.38 ± 4.27 |
| FABQ Physical Activity - Week 4 | 11.41 ± 5.49 | 12.30 ± 5.00 | — |
| FABQ Physical Activity - Week 8 | 11.00 ± 5.55 | 11.68 ± 5.50 | — |
Collected over Baseline-Week 8. Non-serious events are listed at a 5% frequency threshold.
| Group | Deaths | Serious | Other |
|---|---|---|---|
| Osteopathic Manipulative Treatment (OMT) | 0/86 (0%) | 0/86 (0%) | 46/86 (53.5%) |
| No Intervention | 0/86 (0%) | 0/86 (0%) | 32/86 (37.2%) |
| Healthy Control (no Neck Pain) | 0/40 (0%) | 0/40 (0%) | 8/40 (20%) |
| Event | Osteopathic Manipulative Treatment (OMT) | No Intervention | Healthy Control (no Neck Pain) |
|---|---|---|---|
| Neck painMusculoskeletal and connective tissue disorders | 24/86 | 13/86 | 3/40 |
| MyalgiaMusculoskeletal and connective tissue disorders | 19/86 | 10/86 | 4/40 |
| Muscle fatigueMusculoskeletal and connective tissue disorders | 14/86 | 7/86 | 1/40 |
| Back painMusculoskeletal and connective tissue disorders | 8/86 | 1/86 | 0/40 |
| ColdRespiratory, thoracic and mediastinal disorders | 6/86 | 4/86 | 0/40 |
| HeadahceNervous system disorders | 6/86 | 5/86 | 0/40 |
Number of participants who were randomized, including participants who dropped out prior to the baseline (Visit 1) measurement.
| Age, Categorical(Participants) | OMT First, Then No Intervention | No Intervention, Then OMT | Healthy Control (no Neck Pain) | Total |
|---|---|---|---|---|
| <=18 years | 0 | 0 | 0 | 0 |
| Between 18 and 65 years | 43 | 43 | 38 | 124 |
| >=65 years | 1 | 0 | 2 | 3 |
| Sex: Female, Male(Participants) | OMT First, Then No Intervention | No Intervention, Then OMT | Healthy Control (no Neck Pain) | Total |
|---|---|---|---|---|
| Female | 33 | 33 | 21 | 87 |
| Male | 11 | 10 | 19 | 40 |
| Race (NIH/OMB)(Participants) | OMT First, Then No Intervention | No Intervention, Then OMT | Healthy Control (no Neck Pain) | Total |
|---|---|---|---|---|
| American Indian or Alaska Native | 1 | 1 | 0 | 2 |
| Asian | 4 | 1 | 3 | 8 |
| Native Hawaiian or Other Pacific Islander | 0 | 0 | 1 | 1 |
| Black or African American | 1 | 3 | 2 | 6 |
| White | 36 | 36 | 32 | 104 |
| More than one race | 2 | 2 | 0 | 4 |
| Unknown or Not Reported | 0 | 0 | 2 | 2 |
| Ethnicity (NIH/OMB)(Participants) | OMT First, Then No Intervention | No Intervention, Then OMT | Healthy Control (no Neck Pain) | Total |
|---|---|---|---|---|
| Hispanic or Latino | 7 | 2 | 4 | 13 |
| Not Hispanic or Latino | 37 | 39 | 34 | 110 |
| Unknown or Not Reported | 0 | 2 | 2 | 4 |
| Region of Enrollment(participants) | OMT First, Then No Intervention | No Intervention, Then OMT | Healthy Control (no Neck Pain) | Total |
|---|---|---|---|---|
| United States | 49 | 48 | 41 | 138 |
| Average pain(units on a scale) | OMT First, Then No Intervention | No Intervention, Then OMT | Healthy Control (no Neck Pain) | Total |
|---|---|---|---|---|
| Mean | 5.52 ± 1.36 | 5.28 ± 1.74 | .13 ± .33 | 3.74 ± 2.78 |
| Neck Disability Index (NDI)(%) | OMT First, Then No Intervention | No Intervention, Then OMT | Healthy Control (no Neck Pain) | Total |
|---|---|---|---|---|
| Mean | 35.8 ± 9.9 | 37.4 ± 8.9 | 1.9 ± 3.2 | 25.7 ± 1.8 |
| Fear Avoidance Belief Questionnaire (FABQ)(units on a scale) | OMT First, Then No Intervention | No Intervention, Then OMT | Healthy Control (no Neck Pain) | Total |
|---|---|---|---|---|
| Work (out of 42) | 13.84 ± 8.32 | 14.67 ± 8.83 | 4.28 ± 8.31 | 11.11 ± 9.63 |
| Physical Activity (out of 24) | 12.02 ± 5.80 | 12.44 ± 4.17 | 2.38 ± 4.27 | 9.27 ± 6.60 |
1 further baseline measures are reported on the registry.
PDFs hosted by the registry, ClinicalTrials.gov.
Ran from Jun 2014 to primary completion in Nov 2017, 40 months.
Results were first posted in Oct 2026, 8 years 11 months after primary completion.
Of 768 non-industry interventional studies with no phase under Neck Pain, half reached primary completion within 7 months of starting (the median), counting those still running; a quarter within 3 and three quarters within 15. This study's 40 months is above that.
Counting every sponsor, half of 777 studies reached it within 7 months; a quarter within 3 and three quarters within 15.
How these figures are worked out, and which studies are left out of them.
Cholewicki J, Popovich JM Jr, Reeves NP, DeStefano LA, Rowan JJ, Francisco TJ, Prokop LL, Zatkin MA, Lee AS, Sikorskii A, Pathak PK, Choi J, Radcliffe CJ, Rama…PubMed 34719122 ↗
Cholewicki J, Popovich JM Jr, Reeves NP, DeStefano LA, Rowan JJ, Francisco TJ, Prokop LL, Zatkin MA, Lee AS, Sikorskii A, Pathak PK, Choi J, Radcliffe CJ, Rama…PubMed 34719122 ↗
From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗
This study is completed, as verified in Mar 2026. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.